loader2
Login Open ICICI 3-in-1 Account

LUPIN LAUNCHES PENICILLAMINE TABLETS

Published on Mar 02, 2021 15:13

Lupin (Lupin) today announced the launch of Penicillamine Tablets USP, 250 mg, having received an approval from the United States Food and Drug Administration (U.S. FDA) earlier.

Penicillamine Tablets USP, 250 mg, are the generic equivalent of Depen? Tablets, 250 mg, of Mylan Specialty, L.P., and indicated in the treatment of Wilson`s disease, Cystinuria, and in patients with severe, active rheumatoid arthritis who have failed to respond to an adequate trial of conventional therapy.

Penicillamine Tablets USP, 250 mg (RLD: Depen?) had estimated annual sales of USD 5 million in the U.S. (IQVIA MAT December 2020).

Powered by Capital Market - Live News